Department of Medicine 3 – Rheumatology and Immunology

P170: The impact of BC 007 on immune dysregulation in patients with Post-COVID syndrome Feb. 1, 2025 - Aug. 31, 2025 P132: Identification of metabolic checkpoints during osteoclastogenesis and bone turnover March 1, 2024 - Aug. 31, 2025 P155-OA: Intestinal epithelial barrier disruption as the trigger to Prevotella-induced arthritis July 1, 2024 - June 30, 2025 Bewegungsmuster der Hand aus empathokinästhetischen Sensordaten als diagnostische Größe für Krankheitsaktivität bei Patienten mit rheumatischen Erkrankungen (EmpkinS D01) Empatho-Kinaesthetic Sensor Technology (SFB 1483 EmpkinS) July 1, 2021 - June 30, 2025 Empatho-Kinaesthetic Sensor Technology (SFB 1483 EmpkinS) July 1, 2021 - June 30, 2025 P137: Spatial interactions of disease-relevant T-cell clones in Rheumatoid Arthritis April 1, 2024 - Jan. 31, 2025 P144: Microbiota-derived histamine induces resolution of peripheral inflammation via the central nervous system Feb. 1, 2024 - Jan. 31, 2025 P130: Understanding the mechanism of nuclear envelope breakdown during NETosis July 1, 2023 - Dec. 31, 2024 Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. (NeutroCure) Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. Jan. 1, 2020 - Dec. 31, 2024 J091: Glucocorticoid-induced immune-metabolic reprogramming of macrophages Jan. 1, 2022 - June 30, 2024